NEW YORK (GenomeWeb News) — Eurofins Group yesterday said it has acquired three undisclosed companies in Germany, Japan, and the US that deal in custom DNA synthesis, analysis, and proteomic services.
 
Though Eurofins did not name the firms, it said together they employ around 200 people generated more than €20 million ($30 million) in 2006. The company said the acquisitions “should contribute positively” to the company’s financials “from 2008 onwards.” It did not elaborate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.